ICH topic S 7B - The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals

We have adopted this International Scientific Guideline – ICH S7B; CPMP/ICH/423/02

Last updated

13 January 2025

About this guideline

Overseas effective date: November 2005

Categories: ICH | Safety

Non-clinical | Pharmacology and safety pharmacology

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types